Trial NCT01941615

View at ClinicalTrials.gov 
Org. Study IDs: 1241.31
Secondary IDs: 2013-000298-62

Last trial update was posted on 2016-04-11

MeSH Interventions

Ethinyl Estradiol-Norgestrel Combination Ethinyl estradiol, levonorgestrel drug combination

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

N/A

Limitations And Caveats

This trial was prematurely discontinued during the run-in period. During the run-in period, subjects were to receive Microgynon® once daily for 21 to 49 days. The investigational products Deleobuvir + faldaprevir were not administered.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID